Xconomy

APRIL 21, 2017

Rumblings of a new Obamacare replacement surfaced this week, while scientists and their supporters prepared for Saturday’s—a.k.a. Earth Day’s—nationwide Marches for Science. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 49

Study News Pricing Google 49

Xconomy

APRIL 9, 2018

As readers know, we strive to cover a wide range of innovation sectors, from tech and life sciences to healthcare and education—all with a mix of on-the-ground reporting, daily news stories, in-depth features and analysis, and events and conferences.

News 86

News Education Conference Report 86

Xconomy

OCTOBER 14, 2016

AND IN OTHER NEWS…. —New York-based Intercept Pharmaceuticals (NASDAQ: ICPT ) said that the Committee for Medicinal Products for Human Use has recommended conditional approval of obeticholic acid (Ocaliva) in Europe to treat patients with the rare liver disease primary biliary cirrhosis. . Alex Lash contributed to this report.

News 40

News San Diego Incubator Research 40

Xconomy

JUNE 6, 2017

[ Note: Ben Fidler coauthored this report.] There were a few big business-focused “horse race” stories—one company’s stumble was another company’s gain—but much of the news consisted of mid-trial updates that companies produce because, well, it’s ASCO and everyone is watching.

Conference 59

Conference News Pricing Report 59

Xconomy

JULY 1, 2016

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JULY 8, 2016

But the news in our little corner of the world doesn’t stop. —Another health scourge was in the news: hepatitis. Drugs to treat hepatitis C have made huge leaps in effectiveness, providing cures where none previously existed, but also controversial leaps in price. With heavy hearts, let’s get to the roundup.

Pricing 52

Pricing News Journal Startup 52

Xconomy

DECEMBER 9, 2016

President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to hear brief—can we say edited?—arguments

News 40

News Patents Conference Pricing 40

Xconomy

DECEMBER 20, 2016

San Diego-based Acadia (NASDAQ: ACAD ) reported that patients treated in an exploratory study with its drug pimavanserin showed a statistically significant reduction in psychosis compared against a group given a placebo. Investors cheered the news, boosting Acadia’s stock price 13.6 percent to $28.88 in trading Tuesday morning.

San Diego 40

San Diego Statistics Study News 40

Xconomy

OCTOBER 7, 2016

PRICE FIGHTS. —The Institute for Clinical and Economic Review (ICER), whose drug-value analyses set the pharma industry’s teeth on edge , issued a new report on PD-1 inhibitors , part of the first wave of cancer immunotherapy drugs to be approved. With some caveats, ICER recommended lower prices.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

NOVEMBER 11, 2016

Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. Will he take a softer stance on drug prices? Here’s what we know: There’s news to round up. But her near doubling of Trump (62 to 33 percent) didn’t translate into support for drug price controls.

Patents 87

Patents Study Pricing Research 87

Xconomy

JUNE 10, 2016

Plans for new incubators were announced in two different cities. We’ve got those stories, plus a spate of financings and deals, a legal feud, and other news below. Ed Silverman at STAT reported the analyst note first. The new prices don’t reflect rebates and discounts.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Xconomy

AUGUST 5, 2016

Just as many M&A rumors flame out as lead to deals, of course, but the news was enough to give Biogen’s stock price a big bump, and ignite chatter about what a sale of one of biotech’s heavyweights would mean, particularly for the Boston area. The rumors boosted Biogen’s sinking stock price nearly 10 percent.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

JULY 29, 2016

Amongst several companies to report this week, the biggest news came from Gilead Sciences (NASDAQ: GILD ), whose hepatitis C drugs have become some of the top revenue producers in the industry. But as David Holley reports, an experimental treatment from Rhythm Pharmaceuticals has a chance to fill the void.

Startup 40

Startup Study News Report 40

Xconomy

AUGUST 12, 2016

In other Google-related news, Recode reported that Bill Maris, the founder and president of Google Ventures (now called GV), has left the firm and will be replaced by David Krane. The news was a relief for Redwood City, CA-based Heron, which has been waiting for word on the status of its drug since September 2015. In the U.S.,

Google 40

Google Technical Review News Research 40

Both Sides of the Table

JUNE 18, 2010

An investment doesn’t guarantee your product will suddenly be on the investor’s price sheet. Diverse search results include stream updates, blog posts, news articles, photos, videos (versus Twitter/FaceBook1 only). Self-reported 60mm daily unique as of Dec 2009, games played by 250mm people a month (AppData).

Venture Capital 225

Venture Capital Google Web Sites 225

Xconomy

SEPTEMBER 16, 2016

New documents came to light that showed the sugar industry paid for studies downplaying the ties between sugar and heart disease. Meanwhile, there was yet another twist in the ongoing Duchenne muscular dystrophy drama, more biotech buyouts, new startups, and the filing of a long anticipated IPO. . Alex Lash contributed to this report.

Research 40

Research Pricing News Report 40

Xconomy

AUGUST 19, 2016

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Be our guest and try it.).

Technical Review 40

Technical Review Patents .Net Study 40

Tech Zulu Event

NOVEMBER 18, 2011

Typically entrepreneurs doubt themselves because they undervalue their offerings, but it isn’t about creating a product, setting a price and hoping people will buy. Valu e and Exp erience versus Price and Product. Help a Reporter Out (HARO). Blogs and Forums. The best place to find a directory of blogs is AllTop.

Customer 85

Customer Custom Marketing SEO 85

Xconomy

JULY 18, 2016

In early trading Monday, Evoke’s (NASDAQ: EVOK ) stock price was down 72 percent to $3.02 in New York. In about one-third of the sites (13 out of 41), patients in the trial who took placebo reported an improvement in symptomatic diabetic gastroparesis. per share as of 11:30 a.m.

Study 40

Study Sites News Research 40

Xconomy

NOVEMBER 4, 2016

Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. —The Mayo Clinic of Rochester, MN, reported that a misdiagnosis of a heart problem called long QT syndrome led to an unnecessary implant for a young boy.

Research 40

Research Report Pricing Journal 40

Xconomy

SEPTEMBER 23, 2016

Another biopharma executive went before Congress to explain drug price hikes. Let’s start with more on eteplirsen, and round up the rest of the week’s biggest news. Sarepta said it expects to launch eterlipsen at an average annual price of $300,000 per patient, a figure not likely to be challenged by insurers.

Research 40

Research Technical Review Startup Develop 40

Jason Nazar

JANUARY 14, 2009

The type of sites that might link into you are blogs, traditional press online, forums or bulleting boards, or content rich sites that are focused on a similar topic. Create a target list of blogs that could cover your product or content. You can search Technorati to find the most popular blogs on the web across various categories.

Web 62

Web Social Media Content Sites 62

SoCal Delicious

SEPTEMBER 22, 2008

As featured in technology and news publications: Are you new? Heres 5 steps to start exploring: View the "Best Of" list with 50+ essays on viral marketing, gaming, and ads » Get introduced: About this blog, why entrepreneurs and marketers recommend it » Receive updates by email or RSS feed or Twitter.

Startup 29

Startup IP Email Report 29

SoCal CTO

SEPTEMBER 8, 2010

This continues my series of posts: Top 30 Startup Posts for July 2010 Top 30 Startup Posts in June 2010 Top 29 Startup Posts May 2010 Startup CTO Top 30 Posts for April 16 Great Startup Posts from March Here they are: How to Minimize Politics in Your Company - Ben's Blog , August 24, 2010 “Who the f@#k you think you f$&kin’ with.

Startup 191

Startup Venture Capital Blogging CTO Hire 191

SoCal Delicious

OCTOBER 8, 2012

Financial News. Developments Blog. If youre buying a luxury home or just like looking at them, check out this live chat from reporter Lauren Schuker Blum and WSJ.com real estate editor Matthew Strozier. Prices are soaring in the beachfront communities tech types favor, and rents in these. MarketWatch. MarketWatch.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Both Sides of the Table

DECEMBER 5, 2010

This blog post originally appeared in serialized form here on TechCrunch. Suddenly we were all creating blogs on Blogger.com, Typepad & WordPress. We started uploading images of ourselves to our blogs. But the masses didn’t want to blog. But less considered is the fact that the success of the Web 2.0

Social Network 318

Social Network Networking Web 2.0 Startup 318

Both Sides of the Table

MAY 5, 2011

because every community needs its local tech press to report on companies and run conference. I’ve often talked about the NY advantage of having the NY Times, WSJ, Silicon Alley Insider, New York Magazine and even the editor of TechCrunch based there. It’s an awesome source of regional news. Marketing Muscle.

Venture Capital 317

Venture Capital Technical Review Startup Press 317

Frank Addante

MAY 12, 2007

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! ► February (1) What do you do when a reporter you admire misrepre. ► March (1) Office 2.0:

Outsource Development 40

Outsource Development Outsource Software Review Startup 40

Both Sides of the Table

MAY 7, 2011

Sometime around 2003/04 my technology team turned me on to “Spolsky on Software&# a periodic newsletter served up blog style from Joel Spolsky of FogCreek Software, a maker of bug-tracking software. Blogs weren’t popularized yet so it was an oddity for me to read the founder of a software company spewing out advice.

Software Review 285

Software Review Software Blogging Startup 285